AdventHealth Orlando at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

AdventHealth Orlando brings 2 presentations to IDWeek 2026 in Washington. Its program centres on switching complicated urinary tract infections from IV to oral antibiotics and on pneumococcal disease. One study maps which pneumococcal serotypes cause invasive disease in children and adults and how well current vaccines cover them.

OrganizationIDWeek 2026 Attendance
Industry
Fri Oct 23
11:15am–12:00pm
How PO Can You Go? IV to Oral Transition of Antimicrobials for Complicated UTIs
Learning Lounge 2
with GSK
Antimicrobials, resistance and stewardship
Poster
Sat Oct 24
12:15pm–1:30pm
Invasive Pneumococcal Disease (IPD) Across Pediatric and Adult Populations in the PCV20 Era: Serotype Distribution and Vaccine Coverage in an Integrated Health System
Poster Hall B-C · Poster P-1151
I1. Adult Vaccines

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from AdventHealth Orlando

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction